港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

軒竹生物-B

37.180

-5.820-13.53%

成交量：62.95萬

成交額：2,402.89萬

市值：192.59億

市盈率：-30.11

高：43.000

開：43.000

低：36.620

收：43.000

52周最高：96.900

52周最低：23.820

股本：5.18億

香港流通股本：1.61億

量比：0.34

換手率：0.39%

股息：- -

股息率：- -

每股收益(LYR):-1.235

淨資產收益率：--

總資產收益率：--

市淨率：20.01

市盈率(LYR):-30.11

市銷率: 529.69

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

軒竹生物-B(02575)：安奈拉唑鈉腸溶片(安久衞®)治療反流性食管炎中國III期臨床試驗完成全部受試者入組

軒竹生物-B一度飆升60%！吡洛西利片一線適應症近日獲批，入通後資金搶跑佈局

老虎资讯综合

軒竹生物－Ｂ(02575)股價下跌8.15%，現價港幣$43.5

阿斯达克财经

入通靴子落地加速創新價值兑現，軒竹生物-B(02575)迎關鍵配置窗口期

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/02575"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02575","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","market":"HK","secType":"STK","nameCN":"軒竹生物-B","latestPrice":37.18,"timestamp":1774253287786,"preClose":43,"halted":0,"volume":629500,"delay":0,"changeRate":-0.13534883720930233,"floatShares":160701996,"shares":518000000,"eps":-1.234826,"marketStatus":"未開盤","change":-5.82,"latestTime":"03-23 16:08:07","open":43,"high":43,"low":36.62,"amount":24028890,"amplitude":0.148372,"askPrice":37.18,"askSize":500,"bidPrice":36.94,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-1.178,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774315800000},"marketStatusCode":0,"adr":0,"listingDate":1760457600000,"exchange":"SEHK","adjPreClose":43,"openAndCloseTimeList":[[1774229400000,1774238400000],[1774242000000,1774252800000]],"volumeRatio":0.33963912896328197,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","floatShares":160701996,"roa":"--","roe":"--","lyrEps":-1.234826,"volumeRatio":0.33963912896328197,"shares":518000000,"dividePrice":0,"high":43,"amplitude":0.148372,"preClose":43,"low":36.62,"week52Low":23.82,"pbRate":"20.01","psRate":"529.69","week52High":96.9,"institutionHeld":0,"latestPrice":37.18,"committee":0.333333,"eps":-1.234826,"divideRate":0,"volume":629500,"delay":0,"ttmEps":-1.178,"open":43,"prevYearClose":70.5,"prevWeekClose":43,"prevMonthClose":66,"prevQuarterClose":70.5,"fiveDayClose":48.08,"twentyDayClose":62.4,"sixtyDayClose":71.25,"earningDate":1774800000000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02575\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"02575","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02575\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02575\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02575\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02575","date":"2026-03-20","current":-31.561969,"percent":0.952381,"low":-70.039607,"twenty":-56.603099,"median":-54.112473,"eighty":-49.228933,"high":-22.444691,"avg":-52.033745,"sd":7.989224,"marketCap":22271754970},"quantilePoints":[{"date":"2025-10-17","current":-28.93414,"twenty":-27.261252,"median":-24.751919,"eighty":-23.367582,"marketCap":17558430081},{"date":"2025-10-24","current":-50.850969,"twenty":-50.816841,"median":-33.923646,"eighty":-26.424807,"marketCap":30869688284},{"date":"2025-10-31","current":-54.182971,"twenty":-53.663557,"median":-50.808309,"eighty":-28.95487,"marketCap":32941479444},{"date":"2025-11-07","current":-55.367666,"twenty":-55.639174,"median":-53.630543,"eighty":-30.992132,"marketCap":33640708960},{"date":"2025-11-14","current":-54.36116,"twenty":-55.639174,"median":-54.1994,"eighty":-41.200731,"marketCap":33122761170},{"date":"2025-11-21","current":-53.748657,"twenty":-55.319259,"median":-54.136108,"eighty":-50.782713,"marketCap":32734300328},{"date":"2025-11-28","current":-53.384655,"twenty":-55.070724,"median":-54.15954,"eighty":-50.923112,"marketCap":32630710770},{"date":"2025-12-05","current":-54.773392,"twenty":-55.070724,"median":-54.21583,"eighty":-51.627953,"marketCap":33537119402},{"date":"2025-12-12","current":-70.039607,"twenty":-55.665823,"median":-54.261136,"eighty":-53.311356,"marketCap":42963769180},{"date":"2025-12-19","current":-60.019152,"twenty":-56.570931,"median":-54.488669,"eighty":-53.433833,"marketCap":36903780037},{"date":"2025-12-24","current":-59.160975,"twenty":-59.157371,"median":-54.549256,"eighty":-53.581365,"marketCap":36489421805},{"date":"2026-01-02","current":-54.537602,"twenty":-59.158272,"median":-54.690337,"eighty":-53.655303,"marketCap":33770195908},{"date":"2026-01-09","current":-52.983682,"twenty":-59.049917,"median":-54.49123,"eighty":-52.274882,"marketCap":32889684665},{"date":"2026-01-16","current":-58.758617,"twenty":-58.846722,"median":-54.572443,"eighty":-53.169291,"marketCap":36593011363},{"date":"2026-01-23","current":-52.071916,"twenty":-58.705513,"median":-54.4959,"eighty":-52.506318,"marketCap":32397634264},{"date":"2026-01-30","current":-53.326607,"twenty":-57.909955,"median":-54.48995,"eighty":-52.506318,"marketCap":33329940286},{"date":"2026-02-06","current":-57.283358,"twenty":-57.848985,"median":-54.4959,"eighty":-52.506318,"marketCap":35893781847},{"date":"2026-02-13","current":-51.942748,"twenty":-58.578655,"median":-54.516751,"eighty":-52.506318,"marketCap":32734300328},{"date":"2026-02-20","current":-51.153455,"twenty":-58.517685,"median":-54.493565,"eighty":-52.321662,"marketCap":32190455148},{"date":"2026-02-27","current":-53.732962,"twenty":-57.403185,"median":-54.403912,"eighty":-52.138331,"marketCap":34184554140},{"date":"2026-03-06","current":-41.037619,"twenty":-57.295346,"median":-54.261136,"eighty":-51.687579,"marketCap":25897389500},{"date":"2026-03-13","current":-40.849477,"twenty":-57.283358,"median":-54.21583,"eighty":-50.904735,"marketCap":25897389500},{"date":"2026-03-20","current":-35.26408,"twenty":-56.603099,"median":-54.112473,"eighty":-49.228933,"marketCap":22271754970}],"updateTime":1774284900846},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02575\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621714992","title":"軒竹生物-B(02575)：安奈拉唑鈉腸溶片(安久衞®)治療反流性食管炎中國III期臨床試驗完成全部受試者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2621714992","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621714992?lang=zh_tw&edition=fundamental","pubTime":"2026-03-22 18:33","pubTimestamp":1774175605,"startTime":"0","endTime":"0","summary":"智通财经APP讯，轩竹生物-B 发布公告，公司自主研发的创新药安奈拉唑钠肠溶片用于治疗成人反流性食管炎的中国III期临床试验已于近日顺利完成全部500名受试者入组。该项III期临床试验是一项多中心、随机、双盲双模拟、阳性药物平行对照的关键性研究，旨在评估安奈拉唑钠肠溶片治疗中国成年反流性食管炎受试者的有效性和安全性。安全性指标主要为不良事件的发生类型、发生率、严重程度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","02575","BK1191","BK4134"],"gpt_icon":0},{"id":"1130891814","title":"軒竹生物-B一度飆升60%！吡洛西利片一線適應症近日獲批，入通後資金搶跑佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=1130891814","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130891814?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 10:24","pubTimestamp":1773887083,"startTime":"0","endTime":"0","summary":"3月19日，轩竹生物-B一度飙升60%！轩竹股价在3月9日大幅收涨8.30%，当日股票成交额达到4838.75万港元，较年内日均成交额2244万港元，大幅上涨约116%，入通次日公司股票单日成交额继续上涨至6195.59万港元，显示出港股通资金对轩竹生物的“抢跑布局”。实际上，轩竹生物在二级市场交投活跃度快速回升并获资金抢跑布局，主要得益于市场投资者对公司明确的“创新-商业化”投资逻辑的认可。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f3c7b18acd8da97ebbf23072ff5b0a2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575","BK1191"],"gpt_icon":1},{"id":"2620940281","title":"軒竹生物－Ｂ(02575)股價下跌8.15%，現價港幣$43.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2620940281","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620940281?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 13:10","pubTimestamp":1773810600,"startTime":"0","endTime":"0","summary":"[下跌股]轩竹生物－Ｂ(02575) 股价在下午01:10比前收市价下跌8.15%，现股价为港币$43.5。至目前为止，今日最高价为$47.4，而最低价为$43.5。总成交量为36.538万股，总成交金额为港币$1.661千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603181440/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603181440/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","02575"],"gpt_icon":0},{"id":"2620137274","title":"入通靴子落地加速創新價值兑現，軒竹生物-B(02575)迎關鍵配置窗口期","url":"https://stock-news.laohu8.com/highlight/detail?id=2620137274","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620137274?lang=zh_tw&edition=fundamental","pubTime":"2026-03-17 08:26","pubTimestamp":1773707180,"startTime":"0","endTime":"0","summary":"近日，事关创新药的政策利好不断。这对于在二级市场顺利“入通”、核心创新品种一线适应症获批的轩竹生物-B而言，无疑是极大利好。“入通”靴子落地，资金抢跑布局拉长时间线来看，2025年全年，港股通日均成交额为1211亿港元，占港股整体日均成交额的比重达到26.2%。轩悦宁强势挺进乳腺癌一线治疗，引发了业界和市场广泛关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02575","BK1191"],"gpt_icon":0}],"pageSize":4,"totalPage":32,"pageCount":1,"totalSize":126,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02575\",params:#limit:6,delay:false,,,undefined,":[]}}